Войти в систему Зарегистрироваться бесплатно

NeuroVive Pharmaceutical AB Доход

Что обозначает Доход в NeuroVive Pharmaceutical AB?

Доход NeuroVive Pharmaceutical AB является kr79.000k

Какое определение для Доход?



Доход - это прибыль, которую бизнес получает от обычной деловой деятельности, обычно от продажи товаров и предоставления услуг клиентам.

Revenue is also referred to as sales or turnover. Some companies receive revenue from interest, royalties, or other fees. Revenue may refer to business income in general, or it may refer to the amount, in a monetary unit, earned during a period of time, as in "Last year, Company X had revenue of $42 million". Profits or net income generally imply total revenue minus total expenses in a given period.

In accounting, revenue is often referred to as the "top line" due to its position on the income statement at the very top. This is to be contrasted with the "bottom line" which denotes net income.

Доход компаний в Health Care сектор на OTC по сравнению с NeuroVive Pharmaceutical AB

Что делает NeuroVive Pharmaceutical AB?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Компании с доход похож на NeuroVive Pharmaceutical AB